GAS6 and COVID-19: Based on the most recent evidence about the Gas6/TAM axis involvement in COVID-19 severity and considering its well-recognized profibrotic role, such a signaling pathway appears of great clinical interest to not only support the early stratification of patients but also to predict long-term disease sequelae, such as lung fibrosis.